Olr1462 inhibitors are a specialized class of chemical compounds designed to target and inhibit the Olr1462 receptor, which is part of the olfactory receptor family, a subset of G-protein coupled receptors (GPCRs). These receptors are primarily involved in the detection of odorant molecules, playing a crucial role in olfactory signal transduction. The Olr1462 receptor, like other GPCRs, functions by binding to specific ligands, which then trigger a cascade of intracellular events. Inhibitors of Olr1462 are designed to interfere with this process by binding to the receptor and blocking the interaction with its natural ligands, thereby preventing the initiation of downstream signaling pathways. The design and synthesis of Olr1462 inhibitors require a detailed understanding of the receptor's structure, including its active sites and any allosteric sites that may influence receptor activity.
The chemical design of Olr1462 inhibitors focuses on optimizing their affinity and selectivity for the Olr1462 receptor, ensuring that they effectively block receptor activity without affecting other related receptors. This is achieved through various methods, including structure-based drug design, where researchers use computational models to predict how potential inhibitors will interact with the receptor. High-throughput screening of chemical libraries can also be employed to identify compounds that show promising inhibitory activity. Once potential inhibitors are identified, structure-activity relationship (SAR) studies are conducted to refine their chemical structure, enhancing properties such as potency, selectivity, and metabolic stability. The resulting inhibitors often possess a range of chemical features, including diverse core scaffolds, functional groups that enhance binding interactions, and modifications that improve their overall pharmacokinetic properties. By understanding and manipulating these chemical properties, researchers can develop highly effective Olr1462 inhibitors, providing valuable tools for studying the biological functions of this receptor and its role in olfactory signal transduction.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ondansetron | 99614-02-5 | sc-201127 sc-201127A | 10 mg 50 mg | $82.00 $333.00 | 1 | |
Serotonin receptor antagonist, can inhibit GPCR signaling, potentially affecting Olr1462. | ||||||
ZM 241385 | 139180-30-6 | sc-361421 sc-361421A | 5 mg 25 mg | $92.00 $356.00 | 1 | |
Adenosine A2A receptor antagonist, potentially disrupting GPCR signaling pathways including Olr1462. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
Angiotensin II receptor antagonist, can affect GPCR signaling, potentially influencing Olr1462. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $51.00 $171.00 $530.00 | 2 | |
Alpha-2 adrenergic receptor antagonist, potentially impacting GPCR signaling and Olr1462 activity. | ||||||
NOC-18 | 146724-94-9 | sc-202247 sc-202247A sc-202247B sc-202247C | 10 mg 50 mg 100 mg 500 mg | $51.00 $184.00 $305.00 $1122.00 | 18 | |
Dopamine receptor agonist, can modulate GPCR signaling, potentially affecting Olr1462. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
Inhibits Raf kinase, which is involved in MAPK/ERK pathway, potentially influencing Olr1462. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAP kinase inhibitor, can affect signaling pathways possibly linked to Olr1462. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, potentially impacting signaling pathways related to GPCR activity including Olr1462. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor, can disrupt MAPK/ERK pathway, potentially influencing Olr1462 signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, can affect cellular pathways that may be indirectly related to Olr1462 activity. | ||||||